CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-02-15 | JORDEN DAVID EMERSON Director | Sale | −76,313 | $1.15 | $88K | 6,246,429 |
| 2012-02-15 | JORDEN DAVID EMERSON Director | Option exercise | +200,000 | $0.54 | $107K | 6,446,429 |
| 2012-02-15 | JORDEN DAVID EMERSON Director | Option exercise | +178,571 | $0.50 | $89K | 6,625,000 |
| 2012-02-15 | JORDEN DAVID EMERSON Director | Option exercise · Warrant | −200,000 | 701,065 | ||
| 2012-02-15 | JORDEN DAVID EMERSON Director | Option exercise · Warrant | −178,571 | 522,494 | ||
| 2012-02-14 | JORDEN DAVID EMERSON Director | Sale | −27,000 | $1.20 | $32K | 6,322,742 |
| 2012-02-13 | JORDEN DAVID EMERSON Director | Sale | −39,775 | $1.25 | $50K | 6,349,742 |
| 2012-02-13 | Maslan Andrew Scott Chief Financial Officer | Option exercise | +8,961 | $0.54 | $5K | 97,780 |
| 2012-02-13 | Maslan Andrew Scott Chief Financial Officer | Option exercise · Warrant | −8,961 | 477,321 | ||
| 2012-02-08 | ROSENDALE MARTIN P Chief Executive Officer | Conversion | +35,843 | 130,329 | ||
| 2012-02-08 | ROSENDALE MARTIN P Chief Executive Officer | Other acquisition | +2,000 | 132,329 | ||
| 2012-02-08 | Maslan Andrew Scott Chief Financial Officer | Conversion | +17,922 | 87,819 | ||
| 2012-02-08 | Maslan Andrew Scott Chief Financial Officer | Other acquisition | +1,000 | 88,819 | ||
| 2012-02-08 | JORDEN DAVID EMERSON Director | Conversion | +143,370 | 6,381,517 | ||
| 2012-02-08 | JORDEN DAVID EMERSON Director | Other acquisition | +8,000 | 6,389,517 | ||
| 2012-01-17 | ROSENDALE MARTIN P Chief Executive Officer | Other acquisition | +464 | 94,486 | ||
| 2012-01-17 | JORDEN DAVID EMERSON Director | Other acquisition | +1,854 | 6,238,147 | ||
| 2012-01-17 | Maslan Andrew Scott Chief Financial Officer | Other acquisition | +232 | 69,897 | ||
| 2012-01-03 | KEITH STEPHEN Director | Grant or award · NONQUALIFIED OPTION TO PURCHASE SHARES OF COMMON STOCK | +40,000 | 160,000 | ||
| 2012-01-03 | MENDELSOHN CRAIG B Resigned as director 2/9/12 | Grant or award · NONQUALIFIED OPTION TO PURCHASE SHARES OF COMMON STOCK | +30,000 | 95,000 |
Page 14 of 22 · 436 trades